Kaïssa Ouali

4PUBLICATIONS
52CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 23, 2026
Gustave Roussy Immune Score Validation in Patients Treated with Bispecific CD3 T-cell Engagers in Phase I Clinical Trials.

|Feb 12, 2025
AZD8701, an Antisense Oligonucleotide Targeting FOXP3 mRNA, as Monotherapy and in Combination with Durvalumab: A Phase I Trial in Patients with Advanced Solid Tumors.

Lillian L Siu, Sophie Postel-Vinay, Rafael Villanueva-Vázquez

|May 30, 2024
Impact of Clonal Hematopoiesis-Associated Mutations in Phase I Patients Treated for Solid Tumors: An Analysis of the STING Trial.

Julieta Rodriguez, Capucine Baldini, Arnaud Bayle

|Aug 30, 2022
PALLIA 10 score in phase I cancer studies.

Kaïssa Ouali, Christine Mateus, Arianne Laparra

Pageof 1

Frequent Collaborators

3 joint publications

Christophe Massard

2 joint publications

Capucine Baldini

2 joint publications

Francois-Xavier Danlos

2 joint publications

Sophie Postel-Vinay